Phase 2 Sickle Cell Disease clinical trials

21 recruiting Phase 2 sickle cell disease studies in the US. What trial phases mean

Other phases

RecruitingPhase 2NCT06699849

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

Sponsor: CSL Behring

Oakland, CA · Orange, CA · Washington D.C., DC · +17 more sites

RecruitingPhase 2NCT05640271

Tocilizumab for Acute Chest Syndrome

Sponsor: University of Chicago

Chicago, IL

RecruitingPhase 2NCT07023666

Early Screening and Treatment of Heart Complication in Sickle Cell Disease

Sponsor: Inova Health Care Services

Fairfax, VA · Falls Church, VA

RecruitingPhase 2NCT07369024

Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults

Sponsor: Mohsen Saidinejad

Torrance, CA

RecruitingPhase 2NCT07224360

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

Sponsor: CSL Behring

Little Rock, AR · Orange, CA · Hollywood, FL · +6 more sites

RecruitingPhase 2NCT02675959

Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease

Sponsor: New York Medical College

Los Angeles, CA · Gainesville, FL · Valhalla, NY · +1 more sites

RecruitingPhase 2NCT07616154

Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease

Sponsor: St. Jude Children's Research Hospital

Memphis, TN

RecruitingPhase 2NCT06016634

Alendronate for Osteonecrosis in Adults With Sickle Cell Disease

Sponsor: University of California, Davis

Sacramento, CA

RecruitingPhase 2NCT03121001

Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease

Sponsor: University of Illinois at Chicago

Chicago, IL

RecruitingPhase 2NCT06872333

Allo HSCT for High Risk Hemoglobinopathies

Sponsor: Masonic Cancer Center, University of Minnesota

Minneapolis, MN

RecruitingPhase 2NCT05736419

A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)

Sponsor: Memorial Sloan Kettering Cancer Center

Basking Ridge, NJ · Middletown, NJ · Montvale, NJ · +3 more sites

RecruitingPhase 2NCT07175051

Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin

Sponsor: University of Illinois at Chicago

Chicago, IL

RecruitingPhase 2NCT05583721

Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET

Sponsor: St. Jude Children's Research Hospital

Memphis, TN

RecruitingPhase 2NCT06635902

Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease

Sponsor: Suvankar Majumdar

Washington D.C., DC

RecruitingPhase 2NCT06260891

Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial

Sponsor: University of California, San Francisco

Oakland, CA · Durham, NC · Cincinnati, OH · +3 more sites

RecruitingPhase 2NCT03587272

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

Sponsor: Robert Nickel

Washington D.C., DC · Chicago, IL · New York, NY · +2 more sites

RecruitingPhase 2NCT05336201

Cognitive Remediation Intervention to Prepare for Transition of Care

Sponsor: University of Alabama at Birmingham

Birmingham, AL

RecruitingPhase 2NCT01962415

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

Sponsor: Paul Szabolcs

Pittsburgh, PA

RecruitingPhase 2NCT05519111

Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain

Sponsor: Icahn School of Medicine at Mount Sinai

New York, NY

RecruitingPhase 2NCT06358638

Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody

Sponsor: Children's National Research Institute

Washington D.C., DC

RecruitingPhase 2NCT04099966

AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion

Sponsor: Mitchell Cairo

Valhalla, NY

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.